APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiovascular Interventional Guidewires

Compare research editions
View pricing & licenses

Selected research

Industry Research

Cardiovascular Interventional Guidewires Industry Research Report 2026

4 July 2026139 pages

Choose your research edition.

Industry ResearchCardiovascular Interventional Guidewires Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiovascular Interventional Guidewires Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Cardiovascular Interventional Guidewires Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiovascular Interventional Guidewires Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiovascular Interventional Guidewires Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Cardiovascular Interventional Guidewires market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Cardiovascular Interventional Guidewires is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Cardiovascular Interventional Guidewires is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Cardiovascular Interventional Guidewires is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Cardiovascular Interventional Guidewires include ACIST Medical Systems, Asahi Intecc, B. Braun, Biotronik, Cardiovascular Systems, Cook Medical, Galt Medical Corporation, Merit Medical Systems and Philips, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Cardiovascular Interventional Guidewires market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Cardiovascular Interventional Guidewires Market by Company

ACIST Medical Systems

Asahi Intecc

B. Braun

Biotronik

Cardiovascular Systems

Cook Medical

Galt Medical Corporation

Merit Medical Systems

Philips

Teleflex

Terumo Medical

Tryton Medical

Boston Scientific

Guangzhou BrosMed Medical

Medtronic

Abbott

Cardiovascular Interventional Guidewires Segment by Type

Peripheral Interventional Guidewires

Interventional Coronary Guidewires

Cardiovascular Interventional Guidewires Segment by Application

Hospital

Clinic

Others

Cardiovascular Interventional Guidewires Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular Interventional Guidewires market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular Interventional Guidewires and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular Interventional Guidewires.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Cardiovascular Interventional Guidewires manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Cardiovascular Interventional Guidewires by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Cardiovascular Interventional Guidewires in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cardiovascular Interventional Guidewires Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Cardiovascular Interventional Guidewires Sales (k units) of Manufacturers (2021-2026) Table 7. Global Cardiovascular Interventional Guidewires Sales Market Share by Manufacturers (2021-2026) Table 8. Global Cardiovascular Interventional Guidewires Revenue of Manufacturers (2021-2026) Table 9. Global Cardiovascular Interventional Guidewires Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Cardiovascular Interventional Guidewires Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Cardiovascular Interventional Guidewires Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Cardiovascular Interventional Guidewires, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Cardiovascular Interventional Guidewires, Product Type & Application Table 14. Global Cardiovascular Interventional Guidewires Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Cardiovascular Interventional Guidewires by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. ACIST Medical Systems Company Information Table 19. ACIST Medical Systems Business Overview Table 20. ACIST Medical Systems Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. ACIST Medical Systems Cardiovascular Interventional Guidewires Product Portfolio Table 22. ACIST Medical Systems Recent Developments Table 23. Asahi Intecc Company Information Table 24. Asahi Intecc Business Overview Table 25. Asahi Intecc Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Asahi Intecc Cardiovascular Interventional Guidewires Product Portfolio Table 27. Asahi Intecc Recent Developments Table 28. B. Braun Company Information Table 29. B. Braun Business Overview Table 30. B. Braun Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. B. Braun Cardiovascular Interventional Guidewires Product Portfolio Table 32. B. Braun Recent Developments Table 33. Biotronik Company Information Table 34. Biotronik Business Overview Table 35. Biotronik Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Biotronik Cardiovascular Interventional Guidewires Product Portfolio Table 37. Biotronik Recent Developments Table 38. Cardiovascular Systems Company Information Table 39. Cardiovascular Systems Business Overview Table 40. Cardiovascular Systems Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Cardiovascular Systems Cardiovascular Interventional Guidewires Product Portfolio Table 42. Cardiovascular Systems Recent Developments Table 43. Cook Medical Company Information Table 44. Cook Medical Business Overview Table 45. Cook Medical Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Cook Medical Cardiovascular Interventional Guidewires Product Portfolio Table 47. Cook Medical Recent Developments Table 48. Galt Medical Corporation Company Information Table 49. Galt Medical Corporation Business Overview Table 50. Galt Medical Corporation Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Galt Medical Corporation Cardiovascular Interventional Guidewires Product Portfolio Table 52. Galt Medical Corporation Recent Developments Table 53. Merit Medical Systems Company Information Table 54. Merit Medical Systems Business Overview Table 55. Merit Medical Systems Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Merit Medical Systems Cardiovascular Interventional Guidewires Product Portfolio Table 57. Merit Medical Systems Recent Developments Table 58. Philips Company Information Table 59. Philips Business Overview Table 60. Philips Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Philips Cardiovascular Interventional Guidewires Product Portfolio Table 62. Philips Recent Developments Table 63. Teleflex Company Information Table 64. Teleflex Business Overview Table 65. Teleflex Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Teleflex Cardiovascular Interventional Guidewires Product Portfolio Table 67. Teleflex Recent Developments Table 68. Terumo Medical Company Information Table 69. Terumo Medical Business Overview Table 70. Terumo Medical Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Terumo Medical Cardiovascular Interventional Guidewires Product Portfolio Table 72. Terumo Medical Recent Developments Table 73. Tryton Medical Company Information Table 74. Tryton Medical Business Overview Table 75. Tryton Medical Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Tryton Medical Cardiovascular Interventional Guidewires Product Portfolio Table 77. Tryton Medical Recent Developments Table 78. Boston Scientific Company Information Table 79. Boston Scientific Business Overview Table 80. Boston Scientific Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Boston Scientific Cardiovascular Interventional Guidewires Product Portfolio Table 82. Boston Scientific Recent Developments Table 83. Guangzhou BrosMed Medical Company Information Table 84. Guangzhou BrosMed Medical Business Overview Table 85. Guangzhou BrosMed Medical Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Guangzhou BrosMed Medical Cardiovascular Interventional Guidewires Product Portfolio Table 87. Guangzhou BrosMed Medical Recent Developments Table 88. Medtronic Company Information Table 89. Medtronic Business Overview Table 90. Medtronic Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Medtronic Cardiovascular Interventional Guidewires Product Portfolio Table 92. Medtronic Recent Developments Table 93. Abbott Company Information Table 94. Abbott Business Overview Table 95. Abbott Cardiovascular Interventional Guidewires Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Abbott Cardiovascular Interventional Guidewires Product Portfolio Table 97. Abbott Recent Developments Table 98. Global Cardiovascular Interventional Guidewires Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Cardiovascular Interventional Guidewires Sales by Region (2021-2026) & (k units) Table 100. Global Cardiovascular Interventional Guidewires Sales Market Share by Region (2021-2026) Table 101. Global Cardiovascular Interventional Guidewires Sales by Region (2027-2032) & (k units) Table 102. Global Cardiovascular Interventional Guidewires Sales Market Share by Region (2027-2032) Table 103. Global Cardiovascular Interventional Guidewires Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Cardiovascular Interventional Guidewires Revenue Market Share by Region (2021-2026) Table 105. Global Cardiovascular Interventional Guidewires Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Cardiovascular Interventional Guidewires Revenue Market Share by Region (2027-2032) Table 107. North America Cardiovascular Interventional Guidewires Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Cardiovascular Interventional Guidewires Sales by Country (2021-2026) & (k units) Table 109. North America Cardiovascular Interventional Guidewires Sales by Country (2027-2032) & (k units) Table 110. North America Cardiovascular Interventional Guidewires Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Cardiovascular Interventional Guidewires Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Cardiovascular Interventional Guidewires Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Cardiovascular Interventional Guidewires Sales by Country (2021-2026) & (k units) Table 114. Europe Cardiovascular Interventional Guidewires Sales by Country (2027-2032) & (k units) Table 115. Europe Cardiovascular Interventional Guidewires Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Cardiovascular Interventional Guidewires Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Cardiovascular Interventional Guidewires Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Cardiovascular Interventional Guidewires Sales by Country (2021-2026) & (k units) Table 119. Asia Pacific Cardiovascular Interventional Guidewires Sales by Country (2027-2032) & (k units) Table 120. Asia Pacific Cardiovascular Interventional Guidewires Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Cardiovascular Interventional Guidewires Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Cardiovascular Interventional Guidewires Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Cardiovascular Interventional Guidewires Sales by Country (2021-2026) & (k units) Table 124. South America Cardiovascular Interventional Guidewires Sales by Country (2027-2032) & (k units) Table 125. South America Cardiovascular Interventional Guidewires Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Cardiovascular Interventional Guidewires Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Cardiovascular Interventional Guidewires Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Cardiovascular Interventional Guidewires Sales by Country (2021-2026) & (k units) Table 129. Middle East and Africa Cardiovascular Interventional Guidewires Sales by Country (2027-2032) & (k units) Table 130. Middle East and Africa Cardiovascular Interventional Guidewires Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Cardiovascular Interventional Guidewires Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Cardiovascular Interventional Guidewires Sales by Type (2021-2026) & (k units) Table 133. Global Cardiovascular Interventional Guidewires Sales by Type (2027-2032) & (k units) Table 134. Global Cardiovascular Interventional Guidewires Sales Market Share by Type (2021-2026) Table 135. Global Cardiovascular Interventional Guidewires Sales Market Share by Type (2027-2032) Table 136. Global Cardiovascular Interventional Guidewires Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Cardiovascular Interventional Guidewires Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Cardiovascular Interventional Guidewires Revenue Market Share by Type (2021-2026) Table 139. Global Cardiovascular Interventional Guidewires Revenue Market Share by Type (2027-2032) Table 140. Global Cardiovascular Interventional Guidewires Price by Type (2021-2026) & (USD/unit) Table 141. Global Cardiovascular Interventional Guidewires Price by Type (2027-2032) & (USD/unit) Table 142. Global Cardiovascular Interventional Guidewires Sales by Application (2021-2026) & (k units) Table 143. Global Cardiovascular Interventional Guidewires Sales by Application (2027-2032) & (k units) Table 144. Global Cardiovascular Interventional Guidewires Sales Market Share by Application (2021-2026) Table 145. Global Cardiovascular Interventional Guidewires Sales Market Share by Application (2027-2032) Table 146. Global Cardiovascular Interventional Guidewires Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Cardiovascular Interventional Guidewires Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Cardiovascular Interventional Guidewires Revenue Market Share by Application (2021-2026) Table 149. Global Cardiovascular Interventional Guidewires Revenue Market Share by Application (2027-2032) Table 150. Global Cardiovascular Interventional Guidewires Price by Application (2021-2026) & (USD/unit) Table 151. Global Cardiovascular Interventional Guidewires Price by Application (2027-2032) & (USD/unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Cardiovascular Interventional Guidewires Distributors List Table 155. Cardiovascular Interventional Guidewires Customers List Table 156. Cardiovascular Interventional Guidewires Industry Trends Table 157. Cardiovascular Interventional Guidewires Industry Drivers Table 158. Cardiovascular Interventional Guidewires Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Cardiovascular Interventional Guidewires Product Image Figure 5. Global Cardiovascular Interventional Guidewires Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Cardiovascular Interventional Guidewires Market Size (2021-2032) & (US$ Million) Figure 7. Global Cardiovascular Interventional Guidewires Sales (2021-2032) & (k units) Figure 8. Global Cardiovascular Interventional Guidewires Average Price (USD/unit) & (2021-2032) Figure 9. Peripheral Interventional Guidewires Product Image Figure 10. Interventional Coronary Guidewires Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Others Product Image Figure 14. Global Cardiovascular Interventional Guidewires Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Cardiovascular Interventional Guidewires, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Cardiovascular Interventional Guidewires Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Cardiovascular Interventional Guidewires Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Cardiovascular Interventional Guidewires Sales by Region in 2025 Figure 20. Global Cardiovascular Interventional Guidewires Revenue by Region in 2025 Figure 21. North America Cardiovascular Interventional Guidewires Market Size by Country in 2025 Figure 22. North America Cardiovascular Interventional Guidewires Sales Market Share by Country (2021-2032) Figure 23. North America Cardiovascular Interventional Guidewires Revenue Market Share by Country (2021-2032) Figure 24. United States Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Cardiovascular Interventional Guidewires Market Size by Country in 2025 Figure 28. Europe Cardiovascular Interventional Guidewires Sales Market Share by Country (2021-2032) Figure 29. Europe Cardiovascular Interventional Guidewires Revenue Market Share by Country (2021-2032) Figure 30. Germany Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Cardiovascular Interventional Guidewires Market Size by Country in 2025 Figure 41. Asia Pacific Cardiovascular Interventional Guidewires Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Cardiovascular Interventional Guidewires Revenue Market Share by Country (2021-2032) Figure 43. China Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Cardiovascular Interventional Guidewires Market Size by Country in 2025 Figure 52. South America Cardiovascular Interventional Guidewires Sales Market Share by Country (2021-2032) Figure 53. South America Cardiovascular Interventional Guidewires Revenue Market Share by Country (2021-2032) Figure 54. Brazil Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Cardiovascular Interventional Guidewires Market Size by Country in 2025 Figure 58. Middle East and Africa Cardiovascular Interventional Guidewires Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Cardiovascular Interventional Guidewires Revenue Market Share by Country (2021-2032) Figure 60. Egypt Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Cardiovascular Interventional Guidewires Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Cardiovascular Interventional Guidewires Sales Market Share by Type (2021-2032) Figure 66. Global Cardiovascular Interventional Guidewires Revenue Market Share by Type (2021-2032) Figure 67. Global Cardiovascular Interventional Guidewires Price (USD/unit) by Type (2021-2032) Figure 68. Global Cardiovascular Interventional Guidewires Sales Market Share by Application (2021-2032) Figure 69. Global Cardiovascular Interventional Guidewires Revenue Market Share by Application (2021-2032) Figure 70. Global Cardiovascular Interventional Guidewires Price (USD/unit) by Application (2021-2032) Figure 71. Cardiovascular Interventional Guidewires Value Chain Figure 72. Cardiovascular Interventional Guidewires Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Cardiovascular Interventional Guidewires Industry Opportunities and Challenges

Scope & coverage.

Types
  • Peripheral Interventional Guidewires
  • Interventional Coronary Guidewires
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • ACIST Medical Systems
  • Asahi Intecc
  • B. Braun
  • Biotronik
  • Cardiovascular Systems
  • Cook Medical
  • Galt Medical Corporation
  • Merit Medical Systems
  • Philips
  • Teleflex
  • Terumo Medical
  • Tryton Medical
  • Boston Scientific
  • Guangzhou BrosMed Medical
  • Medtronic
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Cardiovascular Interventional Guidewires Market Size (2021-2032)
  4. 2.2.2 Global Cardiovascular Interventional Guidewires Sales (2021-2032)
  5. 2.2.3 Global Cardiovascular Interventional Guidewires Market Average Price (2021-2032)
  6. 2.3 Cardiovascular Interventional Guidewires by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Peripheral Interventional Guidewires
  9. 2.3.3 Interventional Coronary Guidewires
  10. 2.4 Cardiovascular Interventional Guidewires by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Cardiovascular Interventional Guidewires Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Cardiovascular Interventional Guidewires Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Cardiovascular Interventional Guidewires Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Cardiovascular Interventional Guidewires Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Cardiovascular Interventional Guidewires Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Cardiovascular Interventional Guidewires, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Cardiovascular Interventional Guidewires, Product Type & Application
  8. 3.8 Global Manufacturers of Cardiovascular Interventional Guidewires, Established Date
  9. 3.9 Global Cardiovascular Interventional Guidewires Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 ACIST Medical Systems
  2. 4.1.1 ACIST Medical Systems Company Information
  3. 4.1.2 ACIST Medical Systems Business Overview
  4. 4.1.3 ACIST Medical Systems Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 ACIST Medical Systems Cardiovascular Interventional Guidewires Product Portfolio
  6. 4.1.5 ACIST Medical Systems Recent Developments
  7. 4.2 Asahi Intecc
  8. 4.2.1 Asahi Intecc Company Information
  9. 4.2.2 Asahi Intecc Business Overview
  10. 4.2.3 Asahi Intecc Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Asahi Intecc Cardiovascular Interventional Guidewires Product Portfolio
  12. 4.2.5 Asahi Intecc Recent Developments
  13. 4.3 B. Braun
  14. 4.3.1 B. Braun Company Information
  15. 4.3.2 B. Braun Business Overview
  16. 4.3.3 B. Braun Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 B. Braun Cardiovascular Interventional Guidewires Product Portfolio
  18. 4.3.5 B. Braun Recent Developments
  19. 4.4 Biotronik
  20. 4.4.1 Biotronik Company Information
  21. 4.4.2 Biotronik Business Overview
  22. 4.4.3 Biotronik Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Biotronik Cardiovascular Interventional Guidewires Product Portfolio
  24. 4.4.5 Biotronik Recent Developments
  25. 4.5 Cardiovascular Systems
  26. 4.5.1 Cardiovascular Systems Company Information
  27. 4.5.2 Cardiovascular Systems Business Overview
  28. 4.5.3 Cardiovascular Systems Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Cardiovascular Systems Cardiovascular Interventional Guidewires Product Portfolio
  30. 4.5.5 Cardiovascular Systems Recent Developments
  31. 4.6 Cook Medical
  32. 4.6.1 Cook Medical Company Information
  33. 4.6.2 Cook Medical Business Overview
  34. 4.6.3 Cook Medical Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Cook Medical Cardiovascular Interventional Guidewires Product Portfolio
  36. 4.6.5 Cook Medical Recent Developments
  37. 4.7 Galt Medical Corporation
  38. 4.7.1 Galt Medical Corporation Company Information
  39. 4.7.2 Galt Medical Corporation Business Overview
  40. 4.7.3 Galt Medical Corporation Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Galt Medical Corporation Cardiovascular Interventional Guidewires Product Portfolio
  42. 4.7.5 Galt Medical Corporation Recent Developments
  43. 4.8 Merit Medical Systems
  44. 4.8.1 Merit Medical Systems Company Information
  45. 4.8.2 Merit Medical Systems Business Overview
  46. 4.8.3 Merit Medical Systems Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Merit Medical Systems Cardiovascular Interventional Guidewires Product Portfolio
  48. 4.8.5 Merit Medical Systems Recent Developments
  49. 4.9 Philips
  50. 4.9.1 Philips Company Information
  51. 4.9.2 Philips Business Overview
  52. 4.9.3 Philips Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Philips Cardiovascular Interventional Guidewires Product Portfolio
  54. 4.9.5 Philips Recent Developments
  55. 4.10 Teleflex
  56. 4.10.1 Teleflex Company Information
  57. 4.10.2 Teleflex Business Overview
  58. 4.10.3 Teleflex Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Teleflex Cardiovascular Interventional Guidewires Product Portfolio
  60. 4.10.5 Teleflex Recent Developments
  61. 4.11 Terumo Medical
  62. 4.11.1 Terumo Medical Company Information
  63. 4.11.2 Terumo Medical Business Overview
  64. 4.11.3 Terumo Medical Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Terumo Medical Cardiovascular Interventional Guidewires Product Portfolio
  66. 4.11.5 Terumo Medical Recent Developments
  67. 4.12 Tryton Medical
  68. 4.12.1 Tryton Medical Company Information
  69. 4.12.2 Tryton Medical Business Overview
  70. 4.12.3 Tryton Medical Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Tryton Medical Cardiovascular Interventional Guidewires Product Portfolio
  72. 4.12.5 Tryton Medical Recent Developments
  73. 4.13 Boston Scientific
  74. 4.13.1 Boston Scientific Company Information
  75. 4.13.2 Boston Scientific Business Overview
  76. 4.13.3 Boston Scientific Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Boston Scientific Cardiovascular Interventional Guidewires Product Portfolio
  78. 4.13.5 Boston Scientific Recent Developments
  79. 4.14 Guangzhou BrosMed Medical
  80. 4.14.1 Guangzhou BrosMed Medical Company Information
  81. 4.14.2 Guangzhou BrosMed Medical Business Overview
  82. 4.14.3 Guangzhou BrosMed Medical Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Guangzhou BrosMed Medical Cardiovascular Interventional Guidewires Product Portfolio
  84. 4.14.5 Guangzhou BrosMed Medical Recent Developments
  85. 4.15 Medtronic
  86. 4.15.1 Medtronic Company Information
  87. 4.15.2 Medtronic Business Overview
  88. 4.15.3 Medtronic Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Medtronic Cardiovascular Interventional Guidewires Product Portfolio
  90. 4.15.5 Medtronic Recent Developments
  91. 4.16 Abbott
  92. 4.16.1 Abbott Company Information
  93. 4.16.2 Abbott Business Overview
  94. 4.16.3 Abbott Cardiovascular Interventional Guidewires Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Abbott Cardiovascular Interventional Guidewires Product Portfolio
  96. 4.16.5 Abbott Recent Developments
5 Global Cardiovascular Interventional Guidewires Market Scenario by Region
  1. 5.1 Global Cardiovascular Interventional Guidewires Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Cardiovascular Interventional Guidewires Sales by Region: 2021-2032
  3. 5.2.1 Global Cardiovascular Interventional Guidewires Sales by Region: 2021-2026
  4. 5.2.2 Global Cardiovascular Interventional Guidewires Sales by Region: 2027-2032
  5. 5.3 Global Cardiovascular Interventional Guidewires Revenue by Region: 2021-2032
  6. 5.3.1 Global Cardiovascular Interventional Guidewires Revenue by Region: 2021-2026
  7. 5.3.2 Global Cardiovascular Interventional Guidewires Revenue by Region: 2027-2032
  8. 5.4 North America Cardiovascular Interventional Guidewires Market Facts & Figures by Country
  9. 5.4.1 North America Cardiovascular Interventional Guidewires Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Cardiovascular Interventional Guidewires Sales by Country (2021-2032)
  11. 5.4.3 North America Cardiovascular Interventional Guidewires Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Cardiovascular Interventional Guidewires Market Facts & Figures by Country
  16. 5.5.1 Europe Cardiovascular Interventional Guidewires Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Cardiovascular Interventional Guidewires Sales by Country (2021-2032)
  18. 5.5.3 Europe Cardiovascular Interventional Guidewires Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Cardiovascular Interventional Guidewires Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Cardiovascular Interventional Guidewires Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Cardiovascular Interventional Guidewires Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Cardiovascular Interventional Guidewires Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Cardiovascular Interventional Guidewires Market Facts & Figures by Country
  41. 5.7.1 South America Cardiovascular Interventional Guidewires Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Cardiovascular Interventional Guidewires Sales by Country (2021-2032)
  43. 5.7.3 South America Cardiovascular Interventional Guidewires Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Cardiovascular Interventional Guidewires Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Cardiovascular Interventional Guidewires Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Cardiovascular Interventional Guidewires Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Cardiovascular Interventional Guidewires Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Cardiovascular Interventional Guidewires Sales by Type (2021-2032)
  2. 6.1.1 Global Cardiovascular Interventional Guidewires Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Cardiovascular Interventional Guidewires Sales Market Share by Type (2021-2032)
  4. 6.2 Global Cardiovascular Interventional Guidewires Revenue by Type (2021-2032)
  5. 6.2.1 Global Cardiovascular Interventional Guidewires Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Cardiovascular Interventional Guidewires Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Cardiovascular Interventional Guidewires Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Cardiovascular Interventional Guidewires Sales by Application (2021-2032)
  2. 7.1.1 Global Cardiovascular Interventional Guidewires Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Cardiovascular Interventional Guidewires Sales Market Share by Application (2021-2032)
  4. 7.2 Global Cardiovascular Interventional Guidewires Revenue by Application (2021-2032)
  5. 7.2.1 Global Cardiovascular Interventional Guidewires Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Cardiovascular Interventional Guidewires Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Cardiovascular Interventional Guidewires Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Cardiovascular Interventional Guidewires Value Chain Analysis
  2. 8.1.1 Cardiovascular Interventional Guidewires Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Cardiovascular Interventional Guidewires Production Mode & Process
  5. 8.2 Cardiovascular Interventional Guidewires Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Cardiovascular Interventional Guidewires Distributors
  8. 8.2.3 Cardiovascular Interventional Guidewires Customers
9 Global Cardiovascular Interventional Guidewires Analyzing Market Dynamics
  1. 9.1 Cardiovascular Interventional Guidewires Industry Trends
  2. 9.2 Cardiovascular Interventional Guidewires Industry Drivers
  3. 9.3 Cardiovascular Interventional Guidewires Industry Opportunities and Challenges
  4. 9.4 Cardiovascular Interventional Guidewires Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst